Anika Therapeutics | ANIK - Dochód Netto





Dochód Netto Zmiana Data
Abbott USD 1.08B 699M 2026-03
Agenus USD -10.63M 74.49M 2025-12
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -132.73M 163.54M 2026-03
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Halozyme Therapeutics USD 150.05M 291.64M 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -163.56M 164.92M 2026-03
Integra LifeSciences USD -4.62M 2.91M 2026-03
J&J USD 5.24B 119M 2026-03
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
Ligand Pharmaceuticals USD -13.34M 58.13M 2026-03
MacroGenics USD -36.77M 22.62M 2026-03
Merit Medical Systems USD 41M 2.99M 2026-03
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR 1.61B 2.42B 2026-03
Smith & Nephew USD 293M 79M 2025-12
Stryker USD 745M 104M 2026-03
Veracyte USD 28.71M 12.44M 2026-03
Xencor USD -128.92M 122.26M 2026-03
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03